Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M7HZ
|
|||
| Former ID |
DNCL003633
|
|||
| Drug Name |
ISIS-SMNRx
|
|||
| Indication | Spinal muscular atrophy [ICD-11: 8B61] | Phase 3 | [1] | |
| Company |
Biogen Idec; ISIS pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02292537) A Study to Assess the Efficacy and Safety of ISIS-SMN Rx in Patients With Later-onset Spinal Muscular Atrophy. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.